Literature DB >> 31299394

Role of ectopically expressed mtDNA encoded cytochrome c oxidase subunit I (MT-COI) in tumorigenesis.

Rajnish Kumar Singh1, Sunil Kumar Saini2, Gopinath Prakasam2, Ponnuusamy Kalairasan2, Rameshwar N K Bamezai3.   

Abstract

Somatic mutations within mitochondrial DNA (mtDNA) encoded cytochrome c oxidase subunit I (MT-CO1 or MT-COI) are frequent in various cancer types. In addition, perturbation from orchestrated expression of mitochondrial DNA encoded genes is also associated with complex disorders, including cancer. Since codon bias and the mitochondrial translation system restricts functional characterization of over-expressed wild type or mutant mitochondrial DNA encoded genes, the codon optimization and artificial synthesis of entire MT-CO1 allowed us to over-express the wild type and one of its deleterious mutants into the mitochondria of the transfected cells. Ectopically expressed MT-CO1 was observed to efficiently express and localized to mitochondria but showed high level of aggregation under denaturing condition. Over-expression of wild type or mutant variant of MT-CO1 promoted anchorage dependent and independent proliferation potential in in-vitro experiments and introduced the cancer cell metabolic phenotype of high glucose uptake and lactate release. Reactive oxygen species generated in cells over-expressing MT-CO1 variants acted as key effectors mediating differential expression of apoptosis and DNA damage pathway related genes. High ROS generated also down-regulated the expression of global regulators of gene expression, DNMT3A and DNMT3B. The down-regulated expression of DNMTs co-related with differential methylation of the CpG islands in the promoter region of a select set of studied genes, in a manner to promote pro-cancerous phenotype. Apart from assigning the mechanistic role to the MT-CO1 variants and their perturbed expression in cancer development, the present study provides novel insights into the functional role of somatic mutations within MT-CO1 promoting cancer phenotype.
Copyright © 2019 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31299394     DOI: 10.1016/j.mito.2019.07.002

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  4 in total

Review 1.  The Mitochondrial Genome in Aging and Disease and the Future of Mitochondrial Therapeutics.

Authors:  Sanjana Saravanan; Caitlin J Lewis; Bhavna Dixit; Matthew S O'Connor; Alexandra Stolzing; Amutha Boominathan
Journal:  Biomedicines       Date:  2022-02-18

Review 2.  Multiple Mechanisms Regulate Eukaryotic Cytochrome C Oxidase.

Authors:  Rabia Ramzan; Bernhard Kadenbach; Sebastian Vogt
Journal:  Cells       Date:  2021-02-28       Impact factor: 6.600

3.  Thyroid Cancer-Associated Mitochondrial DNA Mutation G3842A Promotes Tumorigenicity via ROS-Mediated ERK1/2 Activation.

Authors:  Sixi Chen; Xinzhu Bao; Hongzhi Chen; Manli Jia; Wen Li; Luyi Zhang; Runxiao Fan; Hezhi Fang; Liqin Jin
Journal:  Oxid Med Cell Longev       Date:  2022-03-15       Impact factor: 7.310

4.  Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1.

Authors:  Wuping Yang; Kenan Zhang; Lei Li; Yawei Xu; Kaifang Ma; Haibiao Xie; Jingcheng Zhou; Lin Cai; Yanqing Gong; Kan Gong
Journal:  J Exp Clin Cancer Res       Date:  2021-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.